Kennedy Postpones Preventive Care Panel Meeting Post Supreme
11 Jul 2025 //
BIOSPACE
Osivax Backs OVX836 Co-Administration with Flu Shot in Phase 2a
11 Jul 2025 //
GLOBENEWSWIRE
Pfizer, Astellas' Xtandi Combo Extends Life in Prostate Cancer
11 Jul 2025 //
FIERCE PHARMA
Capricor Shares Sink After FDA Declines Approval for Muscle Drug
11 Jul 2025 //
REUTERS
Delaware Court Backs Zantac Drugmakers in Cancer Lawsuits
11 Jul 2025 //
REUTERS
US FDA Publishes 200 CRLs From Archive in Transparency Drive
11 Jul 2025 //
REUTERS
Moderna Gets US Approval for Covid Shot in At-Risk Children
11 Jul 2025 //
PRESS RELEASE
Ultragenyx, Mereo Plummet After Rare Diseases Trial Result
11 Jul 2025 //
GLOBENEWSWIRE
AbbVie & IGI Ink Global Deal For ISB 2001 Licensing Rights
11 Jul 2025 //
PRESS RELEASE
Nuclidium raises $99M in Series B for Copper-Based Radiopharma
10 Jul 2025 //
BIOSPACE
Delaware Court Backs Zantac Drugmakers in Cancer Lawsuits
11 Jul 2025 //
REUTERS
Gilead Enlists Global Fund in Access Campaign for New PrEp Med
10 Jul 2025 //
PRESS RELEASE
Merck Nears $10 Billion Deal for Respiratory Drugmaker Verona
10 Jul 2025 //
PRESS RELEASE
US Consumers to Bear High Tariff Impact from Domestic Pharma
09 Jul 2025 //
ECONOMICTIMES
Panacea Biotec, Apotex Settle Collaboration Agreement Breach
09 Jul 2025 //
ECONOMICTIMES
Taiho's DMD asset misses in phase 3 trial
09 Jul 2025 //
PRESS RELEASE
J&J Defeats Generic Drugmakers in Appeal Over Schizophrenia Drug
09 Jul 2025 //
REUTERS
Akash Kedia Warns of Us Pricing Reform Impact on Indian Pharma
07 Jul 2025 //
PHARMABIZ
Dr Raj Nagarkar discusses acute shortages in Indian healthcare
05 Jul 2025 //
PHARMABIZ
Lupin Gets FDA nod for Loteprednol Etabonate Ophthalmic Gel
03 Jul 2025 //
EXPRESSPHARMA
Kennedy Postpones Preventive Care Panel Meeting Post Supreme
11 Jul 2025 //
BIOSPACE
Osivax Backs OVX836 Co-Administration with Flu Shot in Phase 2a
11 Jul 2025 //
GLOBENEWSWIRE
Moderna Gets US Approval for Covid Shot in At-Risk Children
11 Jul 2025 //
PRESS RELEASE
AbbVie & IGI Ink Global Deal For ISB 2001 Licensing Rights
11 Jul 2025 //
PRESS RELEASE
Georg Goeres named CEO of Micropep Technologies for commercial
10 Jul 2025 //
BUSINESSWIRE
Renasant Bio Pioneers Next-Gen ADPKD Small Molecule Treatments
10 Jul 2025 //
BUSINESSWIRE
Xtandi Plus Leuprolide Improves Outcomes in nmHSPC-HRBR
10 Jul 2025 //
BUSINESSWIRE
Stoke, Biogen Unveil Zorevunersen Data for Dravet Syndrome
10 Jul 2025 //
BUSINESSWIRE
Newly Elected Directors of Sinovac Hold the First Board Meeting
10 Jul 2025 //
BUSINESSWIRE
XyloCor Therapeutics Dose First Patient in Phase 2b EXACT-2 Trial
10 Jul 2025 //
BUSINESSWIRE
Aenova Bolsters Drug Solubility Solutions with New Technology
10 Jul 2025 //
PRESS RELEASE
Nectar to Sell Api, Formulation & Menthol Biz to Ceph Lifescience
09 Jul 2025 //
ECONOMICTIMES
Anthem Bioscience Expands Plant Ahead Of ?3,395-Crore IPO
09 Jul 2025 //
BUSINESS STD
BioNxt readies Sublingual Cladribine Program for MS Phase
07 Jul 2025 //
ACCESSWIRE
Axplora Doubles Farmabios Footprint with €35M Expansion
04 Jul 2025 //
PRESS RELEASE
BDMA to review Sigachi Pharma explosion in Hyderabad: RK Agarwal
02 Jul 2025 //
PHARMABIZ
Axcelead, A2 Healthcare Partner to Accelerate Drug R&D
24 Jun 2025 //
BUSINESSWIRE
Nippon Shokubai to Expand Nucleic Acid API Capacity 10x
24 Jun 2025 //
PR NEWSWIRE
Crystallization as a Core Competence in API Manufacturing
17 Jun 2025 //
PRESS RELEASE
DBT to Support Biomanufacturing of APIs to reduce GHG emissions
16 Jun 2025 //
PHARMABIZ
Telangana DCA Intensifies Anti-Counterfeit Drug Drive, Arrests
10 Jul 2025 //
PHARMABIZ
Pharmexcil Alerts Exporters On Botswana Inspection Rule
10 Jul 2025 //
PHARMABIZ
Granules India recalls 33,000 bottles of blood lowering drug
09 Jul 2025 //
ECONOMICTIMES
Sun Pharma Works to Resolve USFDA Issues at 3 Plants
08 Jul 2025 //
ECONOMICTIMES
China Retaliates with Import Restrictions on Medical Devices
06 Jul 2025 //
REUTERS
Sigachi Updates on Fire at Pashamylaram Telangana Plant
04 Jul 2025 //
INDPHARMAPOST
Pharma Industry Seeks Secure Graphics, Data Protection Against
04 Jul 2025 //
PHARMABIZ
Indian Healthcare Grapples with Illegible Prescriptions
03 Jul 2025 //
PHARMABIZ
Govt to Bring in Barcodes to Fight Fake Drug Menace
27 Jun 2025 //
ECONOMICTIMES
Plans to Restrict Open Market Access to Tuberculosis Medicines
27 Jun 2025 //
ECONOMICTIMES
Elucid to Showcase PlaqueIQ™ at SCCT 2025
10 Jul 2025 //
BUSINESSWIRE
Swisslog Healthcare Launches I-Rolly for Auto Pack Solid Packager
10 Jul 2025 //
BUSINESSWIRE
Geneticure Gets US Patent for Renal Denervation Test
10 Jul 2025 //
BUSINESSWIRE
340B Disproportionate Share Hospitals Fail to Reinvest
10 Jul 2025 //
BUSINESSWIRE
Milford Lab's Sanger Test Detects Single Lyme Bacterium
10 Jul 2025 //
BUSINESSWIRE
Homespun AHF Ad Campaigns Target HIV Stigma, STD Testing
10 Jul 2025 //
BUSINESSWIRE
Geneoscopy Invalidate all 20 claim of Exact Sciences' '781 Patent
10 Jul 2025 //
BUSINESSWIRE
Merck Animal Health's Bravecto® Quantum Gets FDA Approval
10 Jul 2025 //
BUSINESSWIRE
Personalis, Tempus Expand Deal for CRC Recurrence Test
10 Jul 2025 //
BUSINESSWIRE
Syngene International launches third year of STEM scholarship
10 Jul 2025 //
#N/A
Ultragenyx, Mereo Plummet After Rare Diseases Trial Result
11 Jul 2025 //
GLOBENEWSWIRE
European Commission Approve Tevimbra for Nasopharyngeal Carcinoma
10 Jul 2025 //
BUSINESSWIRE
Arcus Biosciences' Quemliclustat Receives Orphan Drug Designation
10 Jul 2025 //
BUSINESSWIRE
IASO Bio Gets Orphan Tag In South Korea For Equecabtagene
09 Jul 2025 //
PR NEWSWIRE
Zhimeng Biopharma's KCNQ2/3 Opener Approved for ALS Phase 2/3
09 Jul 2025 //
PR NEWSWIRE
EU Establishes Expert Group for Pediatric and Rare Disease
09 Jul 2025 //
RAPS
ALS Community Urges FDA Approval of NurOwn Stem Cell Therapy
07 Jul 2025 //
ACCESSWIRE
FDA grants Breakthrough Therapy Designation to Lexeo's LX2006
07 Jul 2025 //
GLOBENEWSWIRE
Ema Designates Bexobrutideg for Waldenström Macroglobulinemia
07 Jul 2025 //
GLOBENEWSWIRE
BioCryst names Babar Ghias CFO, Head of Corporate Development
07 Jul 2025 //
GLOBENEWSWIRE
Pfizer, Astellas' Xtandi Combo Extends Life in Prostate Cancer
11 Jul 2025 //
FIERCE PHARMA
Capricor Shares Sink After FDA Declines Approval for Muscle Drug
11 Jul 2025 //
REUTERS
US FDA Publishes 200 CRLs From Archive in Transparency Drive
11 Jul 2025 //
REUTERS
Nuclidium raises $99M in Series B for Copper-Based Radiopharma
10 Jul 2025 //
BIOSPACE
Merck's Doravirine/Islatravir NDA Accepted by FDA
10 Jul 2025 //
BUSINESSWIRE
Tandem AI, Perpetual Medicines Merge to Boost AI Drug Discovery
10 Jul 2025 //
BUSINESSWIRE
Kal Vista Pharmaceuticals Updates Operations, Reports Fiscal Year
10 Jul 2025 //
BUSINESSWIRE
Zai Lab to Announce Q2 2025 Results and Updates on August 7
10 Jul 2025 //
BUSINESSWIRE
Eolas Therapeutics Secures Full Development Rights to AZD4041
10 Jul 2025 //
BUSINESSWIRE
Incyte to Report Second Quarter Financial Results
10 Jul 2025 //
BUSINESSWIRE